The progress of CLL research: towards targeted therapy
An overview of the current treatment landscape of non-Hodgkin lymphoma
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL
First results from Bgb-3111 in CLL and Waldenstrom macroglobulinemia
Which is the best combination therapy in relapsed and refractory multiple myeloma?